From: Long-term clinical and biochemical residue after COVID-19 recovery
Variable | Control N = 120 | Cases N = 120 | Test of significance | P value |
---|---|---|---|---|
Mean ± SD | ||||
ESR (mm/h) | 11.84±2.96 | 44.78±20.99 | t=12.35 | p< 0.001* |
CRP (mg/L) (Min-Max, IQR) | 7.9(4.5–12.0) (7.0–9.5) | 15.75(4.5–136.0) (10.70–28.5) | z=8.25 | p=0.001* |
D.dimer | 0.336±0.161 | 0.494±0.257 | t=4.35 | p< 0.001* |
Ferritin (ng/mL) | 19.29±6.16 | 212.44±81.57 | t=18.74 | p< 0.001* |
WBCS ( × 109/L) | 5.82±1.59 | 7.63±3.51 | t=3.82 | p< 0.001* |
RBCS (million/mcL) | 4.82±0.64 | 4.87±0.63 | t=0.528 | p=0.598 |
HB (gm/dL) | 12.63±1.72 | 13.21±1.74 | t=2.05 | p=0.042* |
HCT(%) | 37.99±4.51 | 38.89±5.25 | t=1.12 | p=0.265 |
MCV (fL) | 79.53±7.68 | 80.61±8.30 | t=0.817 | p=0.415 |
MCH (pg) | 26.40±3.21 | 27.49±3.07 | t=2.11 | p=0.036* |
MCHC (g/dL) | 33.08±1.19 | 34.24±1.19 | t=5.95 | p=0.001* |
RDW (%) | 14.69±2.10 | 14.12±1.68 | t=1.88 | p=0.062 |
PLT (× 103/ mcL) | 238.32±75.23 | 289.24±131.47 | t=2.77 | p=0.006* |
MPV (fL) | 8.62±0.81 | 8.52±1.02 | t=0.643 | p=0.521 |
Neutrophil count percentage | 50.13±11.61 | 74.37±17.48 | t=9.62 | p=0.001* |
Lymphocyte count percentage | 37.0±10.04 | 16.92±14.63 | t=9.45 | p=0.001* |